Oncolytics Biotech, Inc. (ONCY)
Last updated: 2026-10-21 13:36:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Oncolytics Biotech, Inc. (ONCY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.51, with a market capitalization of $65.08M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.44 to $1.32. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$65.08M | |
$0.50 | |
$9.84 | |
$0.24 | |
$0.50 | |
11.41K | |
1.05M | |
-- | |
$1.32 | |
$0.44 | |
-- | |
-- |
Oncolytics Biotech, Inc. (ONCY) Stock Price Today
Oncolytics Biotech, Inc. (ONCY) is currently trading at $0.51 as of 2026-10-21 13:34:00, up 1.28% ($0.01) from the previous close of $0.50
During today's regular trading session, ONCY has traded between $0.24 and $9.84, with a trading volume of 11.41K shares. The current price is near the lower end of today's range.
Oncolytics Biotech, Inc. (ONCY) 7-Day Stock Price Change
Over the past seven days, Oncolytics Biotech, Inc. (ONCY) moved from $0.47 to $0.51, representing a gain of 6.70% ($0.03).
The stock traded between $0.44 and $0.59 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 2.17 million shares, up versus the previous seven-day period, indicating higher trading activity.
ONCY 52-Week Price Position
Position in Range: 7.2%
ONCY is currently trading at $0.51, placing it 7.2% of the way from its 52-week low of $0.44 to its 52-week high of $1.32. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Oncolytics Biotech, Inc. (ONCY)?
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
Oncolytics Biotech, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 29 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Oncolytics Biotech, Inc. (ONCY) Stock on MEXC
Eligible investors can buy real shares of Oncolytics Biotech, Inc. (ONCY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Oncolytics Biotech, Inc. (ONCY) stock price today?
2.Is ONCY stock going up or down today?
3.What is ONCY pre-market price?
4.What is ONCY after-hours price?
5.Is ONCY stock trading now?
6.Where does ONCY sit relative to its 52-week high and low?
7.What sector is Oncolytics Biotech, Inc. in?
8.What is Oncolytics Biotech, Inc.'s market capitalization and where is it listed?
9.How is ONCY valued in terms of P/E ratio and EPS?
10.Does Oncolytics Biotech, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ONCY Stock Calculator
Estimate the value between ONCY shares and USD.
ONCY Shares to USD
1.00 ONCY shares = 0.505 USD
Calculations are estimates based on the latest available price and are for reference only.



